End-of-day quote
Hong Kong S.E.
06:00:00 2024-05-21 pm EDT
|
5-day change
|
1st Jan Change
|
15.88
USD
|
+1.53%
|
|
-6.59%
|
-50.38%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
---|
Capitalization
1 |
17,348
|
17,348
|
-
|
Enterprise Value (EV)
1 |
34,275
|
13,981
|
14,147
|
P/E ratio
|
112
x
|
30.2
x
|
19.1
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
16.1
x
|
5.49
x
|
3.76
x
|
EV / Revenue
|
16.1
x
|
4.42
x
|
3.07
x
|
EV / EBITDA
|
92
x
|
17.6
x
|
11.3
x
|
EV / FCF
|
-18.8
x
|
-16.1
x
|
-297
x
|
FCF Yield
|
-5.32%
|
-6.23%
|
-0.34%
|
Price to Book
|
3.5
x
|
2.96
x
|
2.56
x
|
Nbr of stocks (in thousands)
|
1,178,446
|
1,178,446
|
-
|
Reference price
2 |
14.72
|
14.72
|
14.72
|
Announcement Date
|
3/25/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
2,124
|
3,160
|
4,614
|
EBITDA
1 |
-
|
372.5
|
793.3
|
1,249
|
EBIT
1 |
-
|
343.5
|
661.1
|
1,067
|
Operating Margin
|
-
|
16.17%
|
20.92%
|
23.12%
|
Earnings before Tax (EBT)
1 |
-
|
359.6
|
710
|
1,123
|
Net income
1 |
155.7
|
283.5
|
575.5
|
918.3
|
Net margin
|
-
|
13.35%
|
18.21%
|
19.9%
|
EPS
2 |
0.1800
|
0.2600
|
0.4873
|
0.7726
|
Free Cash Flow
1 |
-
|
-735
|
-870.7
|
-47.67
|
FCF margin
|
-
|
-40.71%
|
-27.55%
|
-1.03%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
Announcement Date
|
11/6/23
|
3/25/24
|
-
|
-
|
Fiscal Period: December |
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
875.9
|
1,392
|
1,702
|
EBITDA
|
-
|
-
|
-
|
EBIT
1 |
168
|
337.6
|
423.4
|
Operating Margin
|
19.18%
|
24.25%
|
24.88%
|
Earnings before Tax (EBT)
1 |
70
|
-
|
-
|
Net income
1 |
56
|
-
|
-
|
Net margin
|
6.39%
|
-
|
-
|
EPS
2 |
0.0400
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
3,519
|
3,367
|
3,201
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-735
|
-871
|
-47.7
|
ROE (net income / shareholders' equity)
|
-
|
8.35%
|
10.2%
|
14.2%
|
ROA (Net income/ Total Assets)
|
-
|
5.57%
|
9.45%
|
12%
|
Assets
1 |
-
|
4,456
|
6,089
|
7,671
|
Book Value Per Share
2 |
-
|
4.210
|
4.980
|
5.750
|
Cash Flow per Share
2 |
-
|
0.3600
|
0.6000
|
0.8100
|
Capex
1 |
-
|
695
|
1,546
|
958
|
Capex / Sales
|
-
|
38.47%
|
48.92%
|
20.76%
|
Announcement Date
|
11/6/23
|
3/25/24
|
-
|
-
|
Last Close Price
14.73
CNY Average target price
28.8
CNY Spread / Average Target +95.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -50.38% | 2.36B | | +37.25% | 723B | | +32.22% | 598B | | -1.96% | 364B | | +20.22% | 331B | | +2.90% | 288B | | +16.60% | 244B | | +9.77% | 210B | | -5.15% | 208B | | +8.62% | 169B |
Other Pharmaceuticals
|